Common Protocols for Peptides: Tirzepatide, Semaglutide, Retatrutide, and CagriSema

When working with peptides for research, it's essential to understand common protocols. Below are typical protocols for some of the most popular research peptides used in lab studies.

Important: Always begin peptide research with the lowest protocol and maintain it consistently for at least 4 weeks before advancing to higher protocols.

1. Tirzepatide

Tirzepatide is a dual-action peptide widely studied for various research applications.

• Low protocol: 2.5 mg per week
• Moderate protocol: 5 mg - 7.5 mg per week
• High protocol: 10 mg - 15 mg per week

2. Semaglutide

Semaglutide, a GLP-1 receptor agonist, has been extensively researched for diverse scientific purposes.

• Low protocol: 0.25 mg - 0.5 mg per week
• Moderate protocol: 1 mg per week
• High protocol: 2.4 mg per week (in select studies)

3. Retatrutide

Retatrutide, known for its triple receptor action, is popular in advanced peptide research settings.

• Low protocol: 1 mg - 2 mg weekly
• Moderate protocol: 4 mg weekly
• High protocol: 8 mg - 12 mg weekly (higher protocols typically experimental)

4. CagriSema (Cagrilintide + Semaglutide Combination)

CagriSema, a combination peptide, is emerging in research exploring synergistic peptide effects. A common formulation is a 50/50 blended vial containing equal amounts of Semaglutide and Cagrilintide.

• Low protocol: 0.5 mg - 1 mg total per week (0.25 mg - 0.5 mg each peptide)
• Moderate protocol: 2 mg total per week (1 mg each peptide)
• High protocol: 4.8 mg total per week (2.4 mg each peptide, used in advanced research)

Important Note: All peptides discussed here are for research use only. Proper handling, precise measurement, and correct storage are crucial for obtaining accurate research results.

Always ensure peptides are reconstituted, stored, and administered according to recommended research protocols.